CEVA INC
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
CEVA$24.45-1.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| Year ended December 31, | |||
|---|---|---|---|
| 2022 | 2023 | 2024 | |
| Cash flows from operating activities: | |||
| Net loss | $(23,183) | $(11,878) | $(8,786) |
| Adjustments required to reconcile net loss to net cash provided by (used in) operating activities: | |||
| Depreciation | 3,190 | 2,887 | 3,046 |
| Amortization of intangible assets | 4,371 | 1,996 | 1,090 |
| Impairment of intangible assets | 3,556 | — | — |
| Equity-based compensation | 14,505 | 16,198 | 15,575 |
| Realized loss (gain), net on sale of available-for-sale marketable securities | 55 | (90) | (14) |
| Amortization of premiums (discounts) on available-for-sale marketable securities | 397 | (124) | (922) |
| Unrealized foreign exchange (gain) loss, net | (351) | (560) | 1,108 |
| Gain on sale of Intrinsix | — | (11,557) | — |
| Remeasurement of marketable equity securities | 2,511 | 2 | 94 |
| Changes in operating assets and liabilities: | |||
| Trade receivables, net | (3,749) | (25) | (6,777) |
| Prepaid expenses and other assets | (1,126) | (4,850) | (4,751) |
| Operating lease right-of-use assets | (1,456) | 3,305 | 1,167 |
| Accrued interest on bank deposits | 144 | (237) | 527 |
| Deferred taxes, net | 7,811 | 6,684 | (68) |
| Trade payables | 511 | (818) | (261) |
| Deferred revenues | (5,493) | (27) | 581 |
| Accrued expenses and other payables | 333 | (182) | 477 |
| Accrued payroll and related benefits | 984 | (3,737) | 2,664 |
| Operating lease liability | 1,504 | (3,273) | (810) |
| Income taxes payable | 2,127 | 67 | (221) |
| Accrued severance pay, net | 283 | (112) | (248) |
| Net cash provided by (used in) operating activities | 6,924 | (6,331) | 3,471 |
| Cash flows from investing activities: | |||
| Business combination | — | (3,600) | — |
| Asset acquisition | — | — | (753) |
| Purchase of property and equipment | (3,499) | (2,884) | (2,955) |
| Proceeds from the sale of Intrinsix, net | — | 30,589 | 540 |
| Investment in bank deposits | (14,000) | (2,000) | (2,000) |
| Proceeds from bank deposits | 30,885 | 6,000 | 10,000 |
| Investment in available-for-sale marketable securities | (49,873) | (40,026) | (46,864) |
| Proceeds from maturity of available-for-sale marketable securities | 18,196 | 10,340 | 29,780 |
| Proceeds from sale of available-for-sale marketable securities | 3,175 | 12,417 | 9,806 |
| Net cash provided by (used in) investing activities | (15,116) | 10,836 | (2,446) |
| Cash flows from financing activities: | |||
| Purchase of treasury stock | (6,785) | (6,163) | (8,456) |
| Proceeds from exercise of stock-based awards | 3,479 | 3,393 | 2,883 |
| Net cash used in financing activities | (3,306) | (2,770) | (5,573) |
| Effect of exchange rate changes on cash and cash equivalents | (370) | 267 | (241) |
| Increase (decrease) in cash and cash equivalents | (11,868) | 2,002 | (4,789) |
| Cash and cash equivalents at the beginning of the year | 33,153 | 21,285 | 23,287 |
| Cash and cash equivalents at the end of the year | $21,285 | $23,287 | $18,498 |
| Year ended December 31, | |||
|---|---|---|---|
| 2022 | 2023 | 2024 | |
| Supplemental information of cash-flows activities: | |||
| Cash paid during the year for: | |||
| Income and withholding taxes | $10,193 | $7,398 | $6,261 |
| Non-cash transactions: | |||
| Transaction costs related to the Intrinsix but unpaid at the end of the year | $— | $25 | $— |
| Property and equipment purchases incurred but unpaid at the end of the year | $25 | $— | $215 |
| Right-of-use assets obtained in the exchange for operating lease liabilities | $5,009 | $1,100 | $1,324 |
| Reconciliation of cash and cash equivalents as shown in the condensed consolidated statements of cash flow: | |||
| Cash and cash equivalents in the Consolidated Balance Sheets | $20,116 | $23,287 | $18,498 |
| Cash and cash equivalents included in assets of discontinued operation | 1,169 | — | — |
| Total cash and cash equivalents in the Consolidated Statements of Cash Flows | $21,285 | $23,287 | $18,498 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.